ORBION PHARMS
GenericsORBION PHARMS is a generic drug manufacturer focused on Neurology.
ORBION PHARMS's Key Drugs
ORBION PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ORBION PHARMS's Recent FDA Approvals
New NDA/BLA approvals for ORBION PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
ORBION PHARMS's Therapeutic Areas
ORBION PHARMS's approved drugs and pipeline span 1 therapeutic area, led by Neurology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ORBION PHARMS's Top Competitors
ORBION PHARMS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ORBION PHARMS Pipeline Snapshot
Active clinical trials for ORBION PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2007-07-02
- Latest
- 2026-02-03
- Applications
- 29